307467
Selection and correct use of emergency contraception by race and ethnicity
Methods: This noncomparative case series enrolled adolescents from reproductive health clinics in 5 metropolitan areas. Participants self-reported race/ethnicity and reason(s) for requesting EC. After reviewing package information, participants indicated whether they would use EC. Study staff reviewed information provided by participants to determine whether they had appropriately self-selected in accordance with package labeling and whether they had correctly used EC (within 72 hours following unprotected sex).
Results: Appropriate self-selection rates in each group were: Latina—90.5% (133/147), Asian/Pacific Islander—89.7% (61/68), African American—81.3% (39/48), White—97.4% (38/39), Multiracial—91.3% (21/23), Other—94.4% (17/18). Percentages of women who correctly used EC (after appropriate self-selection and dispensing) were: Latina—90.7% (117/129), Asian/Pacific Islander—88.5% (54/61), African American—84.8% (28/33), White—86.8% (33/38), Multiracial—85.7% (18/21), Other—86.7% (13/15).
Conclusions: Percentages of participants who appropriately self-selected and correctly used EC were high (81%-97%). The reports of incorrect use are consistent with prior research demonstrating variation in contraceptive adherence by race/ethnicity. Although the single-dose 1.5 mg levonorgestrel EC is now available over-the-counter to women of all ages, pharmacists should serve as resources for teens who request guidance on appropriate self-selection and correct use.
Learning Areas:
Clinical medicine applied in public healthProvision of health care to the public
Learning Objectives:
Describe rates of appropriate self-selection and correct use of an emergency contraceptive by race/ethnicity.
Qualified on the content I am responsible for because: I was a site investigator for this study. My academic focus is adolescents’ use of contraceptive methods, including EC. Over the past 15 years I have authored review articles, manuscripts describing original research and policy statements related to adolescent contraceptive use.
Any relevant financial relationships? Yes
Name of Organization | Clinical/Research Area | Type of relationship |
---|---|---|
Teva | Contraception | Independent Contractor (contracted research and clinical trials) |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.